Nonhuman Primate Reagent Resource (U24 Clinical Trial Not Allowed)

The National Institutes of Health (NIH), through the National Institute of Allergy and Infectious Diseases (NIAID), intends to publish a Notice of Funding Opportunity (NOFO) to support the continuation of the Nonhuman Primate (NHP) Reagent Resource under the cooperative agreement activity code U24. This forecasted opportunity aims to enhance the field of immunological research by supplying crucial NHP-specific reagents. These reagents support rigorous and reproducible studies in NHP models which are vital for understanding and addressing immune-mediated and infectious diseases. The primary objective of this grant is to develop, produce, and distribute immunologic reagents specifically for NHPs that are either unavailable commercially or not optimized for use in these models. The overarching goal of this initiative is to advance the development of treatments, vaccines, and cures for a variety of immune-related conditions and infectious diseases by promoting robust preclinical research using NHPs as critical models. This funding opportunity is expected to be officially posted on August 29, 2025, with applications due by October 28, 2025. The anticipated award and project start date is July 1, 2026. This grant will be offered under the discretionary funding category and will follow a cooperative agreement format. The total program funding is estimated at $1,300,000, although specific award ceilings and floors have not been disclosed. Eligible applicants for this funding include a wide range of organizations such as state and local governments, independent school districts, higher education institutions (both public and private), Native American tribal entities, nonprofits, for-profit organizations (excluding small businesses), small businesses, and public housing authorities. There are no matching fund requirements for applicants. Applications are not being accepted at the current time as this is a forecast notice. This advance notice is meant to allow interested parties ample time to prepare for the upcoming solicitation, encouraging early collaborations and project planning. Investigators with relevant expertise are especially encouraged to consider applying when the NOFO is officially released. For further information, potential applicants are advised to contact Shilpa Kulkarni, Ph.D., at the National Institute of Allergy and Infectious Diseases. Dr. Kulkarni can be reached at 240-747-7365 or via email at shilpa.kulkarni@nih.gov.